U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Decreased phosphoribosylpyrophosphate synthetase level

MedGen UID:
1698029
Concept ID:
C5139359
Finding
HPO: HP:0032460

Definition

Abnormally reduced level of the enzyme phosphoribosyl pyrophosphatesynthetase, which catalyzes the synthesis of PP-ribose-P from ATP and ribose-5-phosphate. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVDecreased phosphoribosylpyrophosphate synthetase level

Conditions with this feature

Charcot-Marie-Tooth disease X-linked recessive 5
MedGen UID:
374254
Concept ID:
C1839566
Disease or Syndrome
X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5), part of the spectrum of PRPS1-related disorders, is characterized by peripheral neuropathy, early-onset (prelingual) bilateral profound sensorineural hearing loss, and optic neuropathy. The onset of peripheral neuropathy is between ages five and 12 years. The lower extremities are affected earlier and more severely than upper extremities. Initial manifestations often include foot drop or gait disturbance. Onset of visual impairment is between ages seven and 20 years. Intellect and life span are normal. Carrier females do not have findings of CMTX5.

Professional guidelines

PubMed

de Brouwer AP, van Bokhoven H, Nabuurs SB, Arts WF, Christodoulou J, Duley J
Am J Hum Genet 2010 Apr 9;86(4):506-18. doi: 10.1016/j.ajhg.2010.02.024. PMID: 20380929Free PMC Article

Recent clinical studies

Diagnosis

Jing X, Wang XJ, Zhang T, Zhu W, Fang Y, Wu H, Liu X, Ma D, Ji X, Jiang Y, Liu K, Chen X, Shi Y, Zhang Y, Shi M, Qiu W, Zhao R
Cancer Res 2019 Sep 15;79(18):4650-4664. Epub 2019 Jun 28 doi: 10.1158/0008-5472.CAN-18-2486. PMID: 31253668
Zikánová M, Wahezi D, Hay A, Stiburková B, Pitts C 3rd, Mušálková D, Škopová V, Barešová V, Soucková O, Hodanová K, Živná M, Stránecký V, Hartmannová H, Hnízda A, Bleyer AJ, Kmoch S
Rheumatology (Oxford) 2018 Jul 1;57(7):1180-1185. doi: 10.1093/rheumatology/key041. PMID: 30423175Free PMC Article
Al-Maawali A, Dupuis L, Blaser S, Heon E, Tarnopolsky M, Al-Murshedi F, Marshall CR, Paton T, Scherer SW; FORGE Canada Consortium, Roelofsen J, van Kuilenburg AB, Mendoza-Londono R
Eur J Hum Genet 2015 Mar;23(3):310-6. Epub 2014 Jun 25 doi: 10.1038/ejhg.2014.112. PMID: 24961627Free PMC Article
Becker MA, Kim M
J Biol Chem 1987 Oct 25;262(30):14531-7. PMID: 2444588
Zoref E, De Vries A, Sperling O
J Clin Invest 1975 Nov;56(5):1093-9. doi: 10.1172/JCI108183. PMID: 171280Free PMC Article

Prognosis

Jing X, Wang XJ, Zhang T, Zhu W, Fang Y, Wu H, Liu X, Ma D, Ji X, Jiang Y, Liu K, Chen X, Shi Y, Zhang Y, Shi M, Qiu W, Zhao R
Cancer Res 2019 Sep 15;79(18):4650-4664. Epub 2019 Jun 28 doi: 10.1158/0008-5472.CAN-18-2486. PMID: 31253668

Clinical prediction guides

Jing X, Wang XJ, Zhang T, Zhu W, Fang Y, Wu H, Liu X, Ma D, Ji X, Jiang Y, Liu K, Chen X, Shi Y, Zhang Y, Shi M, Qiu W, Zhao R
Cancer Res 2019 Sep 15;79(18):4650-4664. Epub 2019 Jun 28 doi: 10.1158/0008-5472.CAN-18-2486. PMID: 31253668
Liu H, Peng X, Zhao F, Zhang G, Tao Y, Luo Z, Li Y, Teng M, Li X, Wei S
Biochem Biophys Res Commun 2009 Feb 20;379(4):1120-5. Epub 2009 Jan 20 doi: 10.1016/j.bbrc.2009.01.034. PMID: 19161981
Rocchigiani M, Sestini S, Micheli V, Pescaglini M, Jacomelli G, Hayek G, Pompucci G
Neuropediatrics 1995 Dec;26(6):288-92. doi: 10.1055/s-2007-979776. PMID: 8719742
Torrelio BM, Paz MA, Gallop PM
Mech Ageing Dev 1982 Jun;19(2):147-58. doi: 10.1016/0047-6374(82)90006-9. PMID: 6180262
Planet G, Fox IH
J Biol Chem 1976 Oct 10;251(19):5839-44. PMID: 972142

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...